Mechanisms of resistance to alkylating agents

od Damia, G., D‘Incalci, M.
Wydane 1998

Distribution and activity of doxorubicin combined with SDZ PSC 833 in mice with P388 and P388/DOX leukaemia.

od Colombo, T., Gonzalez Paz, O., D'Incalci, M.
Wydane 1996

Characterization of a protein recognizing minor groove binders-damaged DNA.

od Colella, G, Bonfanti, M, D'Incalci, M, Broggini, M
Wydane 1996

Introduction of wild-type p53 in a human ovarian cancer cell line not expressing endogenous p53.

od Vikhanskaya, F, Erba, E, D'Incalci, M, Broggini, M
Wydane 1994

O6-methylguanine inhibits the binding of transcription factors to DNA.

od Bonfanti, M, Broggini, M, Prontera, C, D'Incalci, M
Wydane 1991

Response of chemically induced primary colon tumours of the mouse to flavone acetic acid (NSC 347 512).

od Pratesi, G., Manzotti, C., Damia, G., D'Incalci, M.
Wydane 1988

Time dependence of the in vitro cytotoxicity of hexamethylmelamine and its metabolites.

od D'Incalci, M., Erba, E., Balconi, G., Morasca, L., Garattini, S.
Wydane 1980

Response to flavone acetic acid (NSC 347512) of primary and metastatic human colorectal carcinoma xenografts.

od Giavazzi, R., Garofalo, A., Damia, G., Garattini, S., D'Incalci, M.
Wydane 1988

Mismatch repair deficiency is associated with resistance to DNA minor groove alkylating agents

od Colella, G, Marchini, S, D'Incalci, M, Brown, R, Broggini, M
Wydane 1999

Trabectedin, a drug acting on both cancer cells and the tumour microenvironment

od D'Incalci, M, Badri, N, Galmarini, C M, Allavena, P
Wydane 2014

Distamycin A and tallimustine inhibit TBP binding and basal in vitro transcription.

od Bellorini, M, Moncollin, V, D'Incalci, M, Mongelli, N, Mantovani, R
Wydane 1995

Mechanism of cytotoxicity of 5,10-dideazatetrahydrofolic acid in human ovarian carcinoma cells in vitro and modulation of the drug activity by folic or folinic acid.

od Erba, E., Sen, S., Sessa, C., Vikhanskaya, F. L., D'Incalci, M.
Wydane 1994

Synergism between 5-fluorouracil and N-methylformamide in HT29 human colon cancer line.

od Laudonio, N., Zupi, G., Erba, E., Leonetti, C., D'Incalci, M.
Wydane 1990

3-methyladenine-DNA-glycosylase and O6-alkyl guanine-DNA-alkyltransferase activities and sensitivity to alkylating agents in human cancer cell lines.

od Damia, G., Imperatori, L., Citti, L., Mariani, L., D'Incalci, M.
Wydane 1996

Role of membrane folate-binding protein in the cytotoxicity of 5,10-dideazatetrahydrofolic acid in human ovarian carcinoma cell lines in vitro.

od Sen, S., Erba, E., D'Incalci, M., Bottero, F., Canevari, S., Tomassetti, A.
Wydane 1996

Dynamics of cell cycle phase perturbations by trabectedin (ET‐743) in nucleotide excision repair (NER)‐deficient and NER‐proficient cells, unravelled by a novel mathematical simula...

od Tavecchio, M., Natoli, C., Ubezio, P., Erba, E., D’Incalci, M.
Wydane w Cell Prolif (2007)

Distamycins inhibit the binding of OTF-1 and NFE-1 transfactors to their conserved DNA elements.

od Broggini, M, Ponti, M, Ottolenghi, S, D'Incalci, M, Mongelli, N, Mantovani, R
Wydane 1989

Measurement of the sequence specificity of covalent DNA modification by antineoplastic agents using Taq DNA polymerase.

od Ponti, M, Forrow, S M, Souhami, R L, D'Incalci, M, Hartley, J A
Wydane 1991

α-Bromoacryloyl derivative of distamycin A (PNU 151807): a new non-covalent minor groove DNA binder with antineoplastic activity

od Marchini, S, Cirò, M, Gallinari, F, Geroni, C, Cozzi, P, D'Incalci, M, Broggini, M
Wydane 1999

Treatment with inhibitors of polyamine biosynthesis, which selectively lower intracellular spermine, does not affect the activity of alkylating agents but antagonizes the cytotoxic...

od Desiderio, M. A., Bergamaschi, D., Mascellani, E., De Feudis, P., Erba, E., D'Incalci, M.
Wydane 1997